NYRADA INC BOARD CHANGES

• Global pharmaceutical leader, Dr. Gisela Mautner appointed as Non-Executive Director
• Dr. Mautner brings over 20 years of extensive leadership experience across operational, medical, and scientific advisory roles covering multiple therapeutic areas
• Non-Executive Director, Peter Marks retires from the Board having supported Nyrada through its IPO and key first years as a listed company